AGP Picks
View all

Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on May 19, 2026

Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
EuroPCR 2026: DynamX® Bioadaptor von Elixir Medical zeigt in der Langzeit-Nachbeobachtung signifikant niedrigere Ereignisraten als ein medikamentenfreisetzender Stent
EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent
El bioadaptador DynamX® de Elixir Medical demuestra tasas de acontecimientos significativamente inferiores a las de los stents liberadores de fármacos
Le Bioadaptateur DynamX®  d’Elixir Medical démontre une réduction significative des taux d’événements coronariens par rapport à un stent à élution médicamenteuse
EuroPCR 2026: DynamX® Bioadaptor di Elixir Medical mostra tassi di eventi significativamente inferiori rispetto allo stent a rilascio di farmaco
EuroPCR 2026: Bioadaptator DynamX® firmy Elixir Medical wykazuje istotne obniżenie występowania zdarzeń niepożądanych
Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
Clearmind Medicine Announces 1-for-10 Reverse Share Split
GenoSafe advances CLIA pathway for transatlantic ATMP development
HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy
FEATOL Introduces Ergonomic Wrist Support for Modern Repetitive Strain Challenges
Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development
AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy Initiative
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial
Unaudited Preliminary Results for the Year Ended December 31, 2025
Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Potomac Health News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.